rs114759170
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000159.4(GCDH):c.1085C>A(p.Ala362Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000888 in 1,614,112 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000159.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCDH | NM_000159.4 | c.1085C>A | p.Ala362Asp | missense_variant, splice_region_variant | 11/12 | ENST00000222214.10 | NP_000150.1 | |
GCDH | NM_013976.5 | c.1085C>A | p.Ala362Asp | missense_variant, splice_region_variant | 11/12 | NP_039663.1 | ||
GCDH | NR_102316.1 | n.1248C>A | splice_region_variant, non_coding_transcript_exon_variant | 11/12 | ||||
GCDH | NR_102317.1 | n.1466C>A | splice_region_variant, non_coding_transcript_exon_variant | 10/11 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00423 AC: 643AN: 152134Hom.: 4 Cov.: 31
GnomAD3 exomes AF: 0.00119 AC: 298AN: 251392Hom.: 2 AF XY: 0.00104 AC XY: 141AN XY: 135908
GnomAD4 exome AF: 0.000539 AC: 788AN: 1461860Hom.: 3 Cov.: 32 AF XY: 0.000479 AC XY: 348AN XY: 727236
GnomAD4 genome AF: 0.00424 AC: 645AN: 152252Hom.: 4 Cov.: 31 AF XY: 0.00419 AC XY: 312AN XY: 74436
ClinVar
Submissions by phenotype
Glutaric aciduria, type 1 Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 12, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 11, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
GCDH-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at